Synthesis and molecular docking study of new thiazolidinones incorporating a benzoate moiety as anti-HepG2 cancer agents, EGFR inhibitors and apoptosis inducers
Abstract:Synthesis of new anticancer candidates with protein kinases inhibitory potency is a major goal of pharmaceutical science and synthetic research. This current work represents the synthesis of a series of substituted thiazolidinones incorporating a benzoate moiety, starting from 4-formylphenyl benzoate 1a and 4-formyl-2-methoxyphenyl benzoate 1b. Most prepared thiazolidinones 5a-j, 7a-h and 9a-j, were evaluated in vitro for their potential anticancer activity against three cell lines (HepG2, MCF-7 and HeLa). The… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.